Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Beyond Your CLL Diagnosis: Comprehensive Health Management

Tuesday, September 17, 2024 at 10:00 – 11:30 AM PT, 11:00 AM – 12:30 PM MT, 12:00– 1:30 PM CT, 1:00 – 2:30 PM ET
 (Duration 90 minutes)

Description

Receiving a diagnosis of Chronic Lymphocytic Leukemia (CLL) is often the beginning of your healthcare journey. This webinar is designed to address the multifaceted health challenges that accompany CLL, beyond the primary disease.

Join us as nurse practitioner Amy Goodrich delves into critical aspects such as cardiovascular health, bone health, and the increased risk of secondary cancers. We will also explore the psychological impacts of CLL, including anxiety and mental health concerns, as well as strategies for preventing and managing infections. This holistic approach aims to empower patients with the knowledge and tools to maintain overall well-being while navigating their CLL journey. Whether you are newly diagnosed or have been living with CLL for some time, this webinar offers valuable insights and practical advice to support your comprehensive health management.

Advanced Questions

Ask your question in advance of the event by emailing [email protected] by Friday, September 13th. Please include “Beyond Diagnosis Webinar” in the subject line.

Questions asked in advance are provided to the speaker in preparation for the event. Questions that are applicable to more than one person and written succinctly have a higher chance of being asked by the moderator.

Speakers

Welcome:
RB Headshot 2_Color_July 2023

Robyn Brumble, MSN, RN
Director of Scientific Affairs & Research
CLL Society

Moderator:
Terry Evans - CLL Society

Terry Evans
24-year CLL Patient and Advocate
Director, CLL Society Support Network

Speaker:
Any Goodrich -CLL Society

Amy L. Goodrich, CRNP
Nurse Practitioner
Johns Hopkins Kimmel Cancer Center

Find CLL Society on Social Media

Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.

This program was made possible by generous donors and Astra Zeneca, BeiGene, and Genentech.